|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Cofactor-and substrate-assisted activation of factor viia
|
|
Structure:
|
 |
Factor viia. Chain: l. Fragment: light chain. Engineered: yes. Other_details: n-terminal truncation. Factor viia. Chain: h. Fragment: heavy chain. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
1.69Å
|
R-factor:
|
0.209
|
R-free:
|
0.225
|
|
|
Authors:
|
 |
K.Sichler,D.W.Banner,A.D'Arcy,K.P.Hopfner,R.Huber,W.Bode,G.B.Kresse, E.Kopetzki,H.Brandstetter
|
Key ref:
|
 |
K.Sichler
et al.
(2002).
Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions.
J Mol Biol,
322,
591-603.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
12-Dec-01
|
Release date:
|
18-Sep-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H:
E.C.3.4.21.21
- coagulation factor VIIa.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolyzes one Arg-|-Ile bond in factor X to form factor Xa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
322:591-603
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions.
|
|
K.Sichler,
D.W.Banner,
A.D'Arcy,
K.P.Hopfner,
R.Huber,
W.Bode,
G.B.Kresse,
E.Kopetzki,
H.Brandstetter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Factor VIIa initiates the extrinsic coagulation cascade; this event requires a
delicately balanced regulation that is implemented on different levels,
including a sophisticated multi-step activation mechanism of factor VII. Its
central role in hemostasis and thrombosis makes factor VIIa a key target of
pharmaceutical research. We succeeded, for the first time, in recombinantly
producing N-terminally truncated factor VII (rf7) in an Escherichia coli
expression system by employing an oxidative, in vitro, folding protocol, which
depends critically on the presence of ethylene glycol. Activated recombinant
factor VIIa (rf7a) was crystallised in the presence of the reversible S1-site
inhibitor benzamidine. Comparison of this 1.69A crystal structure with that of
an inhibitor-free and sulphate-free, but isomorphous crystal form identified
structural details of factor VIIa stimulation. The stabilisation of
Asp189-Ser190 by benzamidine and the capping of the intermediate helix by a
sulphate ion appear to be sufficient to mimic the disorder-order transition
conferred by the cofactor tissue factor (TF) and the substrate factor X. Factor
VIIa shares with the homologous factor IXa, but not factor Xa, a bell-shaped
activity modulation dependent on ethylene glycol. The ethylene glycol-binding
site of rf7a was identified in the vicinity of the 60 loop. Ethylene glycol
binding induces a significant conformational rearrangement of the 60 loop. This
region serves as a recognition site of the physiologic substrate, factor X,
which is common to both factor VIIa and factor IXa. These results provide a
mechanistic framework of substrate-assisted catalysis of both factor VIIa and
factor IXa.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Figure 5. Overview of rf7a^BA. The protein is shown in
ribbon representation (blue, catalytic domain, grey,
EGF2-domain), the residues of the catalytic triad, the inhibitor
benzamidine, the four sulphate groups and the glycerol moiety
are shown in stick representation, and the calcium ion is shown
as a green ball.
|
 |
Figure 7.
Figure 7. A stereo view of the 170 loop and the
intermediate helix. Orange, arrow pointing to the intermediate
helix (Met164-Ser170B) and Ser170H-Cys182; pink, insertion loop
(Arg170C-Asp170G); green, Trp215-Arg230; purple, sulphate; light
blue, disulfide bond Cys168-Cys182; white ball, water. Residues
Met164, Cys168, Gln170A-Asn175, Cys182, Trp215 and Arg230 are
shown including their side-chains, for the other residues, only
the backbone atoms are shown. The factor VIIa specific insertion
loop Arg170C-Asp170G and the sulphate groups are shown with
their 2F[o] -F[c] electron density maps. The hydrogen bonds
stabilising the sulphate groups are indicated by white dotted
lines.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2002,
322,
591-603)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.S.Craik,
M.J.Page,
and
E.L.Madison
(2011).
Proteases as therapeutics.
|
| |
Biochem J,
435,
1.
|
 |
|
|
|
|
 |
P.Goettig,
V.Magdolen,
and
H.Brandstetter
(2010).
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
|
| |
Biochimie,
92,
1546-1567.
|
 |
|
|
|
|
 |
E.Persson,
and
O.H.Olsen
(2009).
Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
|
| |
FEBS J,
276,
3099-3109.
|
 |
|
|
|
|
 |
T.Zögg,
and
H.Brandstetter
(2009).
Activation mechanisms of coagulation factor IX.
|
| |
Biol Chem,
390,
391-400.
|
 |
|
|
|
|
 |
T.Zögg,
and
H.Brandstetter
(2009).
Structural basis of the cofactor- and substrate-assisted activation of human coagulation factor IXa.
|
| |
Structure,
17,
1669-1678.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
O.H.Olsen,
K.D.Rand,
H.Østergaard,
and
E.Persson
(2007).
A combined structural dynamics approach identifies a putative switch in factor VIIa employed by tissue factor to initiate blood coagulation.
|
| |
Protein Sci,
16,
671-682.
|
 |
|
|
|
|
 |
C.M.Colina,
D.Venkateswarlu,
R.Duke,
L.Perera,
and
L.G.Pedersen
(2006).
What causes the enhancement of activity of factor VIIa by tissue factor?
|
| |
J Thromb Haemost,
4,
2726-2729.
|
 |
|
|
|
|
 |
K.D.Rand,
T.J.Jørgensen,
O.H.Olsen,
E.Persson,
O.N.Jensen,
H.R.Stennicke,
and
M.D.Andersen
(2006).
Allosteric activation of coagulation factor VIIa visualized by hydrogen exchange.
|
| |
J Biol Chem,
281,
23018-23024.
|
 |
|
|
|
|
 |
S.P.Bajaj,
A.E.Schmidt,
S.Agah,
M.S.Bajaj,
and
K.Padmanabhan
(2006).
High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.
|
| |
J Biol Chem,
281,
24873-24888.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.G.Olivero,
C.Eigenbrot,
R.Goldsmith,
K.Robarge,
D.R.Artis,
J.Flygare,
T.Rawson,
D.P.Sutherlin,
S.Kadkhodayan,
M.Beresini,
L.O.Elliott,
G.G.DeGuzman,
D.W.Banner,
M.Ultsch,
U.Marzec,
S.R.Hanson,
C.Refino,
S.Bunting,
and
D.Kirchhofer
(2005).
A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo.
|
| |
J Biol Chem,
280,
9160-9169.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.R.Maun,
C.Eigenbrot,
H.Raab,
D.Arnott,
L.Phu,
S.Bullens,
and
R.A.Lazarus
(2005).
Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.
|
| |
Protein Sci,
14,
1171-1180.
|
 |
|
|
|
|
 |
J.Hewitt,
J.N.Ballard,
T.N.Nelson,
V.C.Smith,
T.A.Griffiths,
S.Pritchard,
J.K.Wu,
L.D.Wadsworth,
B.Casey,
and
R.T.MacGillivray
(2005).
Severe FVII deficiency caused by a new point mutation combined with a previously undetected gene deletion.
|
| |
Br J Haematol,
128,
380-385.
|
 |
|
|
|
|
 |
M.J.Page,
R.T.Macgillivray,
and
E.Di Cera
(2005).
Determinants of specificity in coagulation proteases.
|
| |
J Thromb Haemost,
3,
2401-2408.
|
 |
|
|
|
|
 |
W.Bode
(2005).
The structure of thrombin, a chameleon-like proteinase.
|
| |
J Thromb Haemost,
3,
2379-2388.
|
 |
|
|
|
|
 |
A.O.Pineda,
C.J.Carrell,
L.A.Bush,
S.Prasad,
S.Caccia,
Z.W.Chen,
F.S.Mathews,
and
E.Di Cera
(2004).
Molecular dissection of Na+ binding to thrombin.
|
| |
J Biol Chem,
279,
31842-31853.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Peyvandi,
R.De Cristofaro,
I.Garagiola,
R.Palla,
S.Akhavan,
R.Landolfi,
and
P.M.Mannucci
(2004).
The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency.
|
| |
Br J Haematol,
127,
576-584.
|
 |
|
|
|
|
 |
M.V.Midathada,
P.Mehta,
M.Waner,
and
L.M.Fink
(2004).
Recombinant factor VIIa in the treatment of bleeding.
|
| |
Am J Clin Pathol,
121,
124-137.
|
 |
|
|
|
|
 |
K.Sichler,
E.Kopetzki,
R.Huber,
W.Bode,
K.P.Hopfner,
and
H.Brandstetter
(2003).
Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop.
|
| |
J Biol Chem,
278,
4121-4126.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |